BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans

Abstract Background Interferons (IFNs) are key cytokines that drive immune responses against infections and cancer, yet few therapies have successfully leveraged IFN signaling for cancer treatment. Long noncoding RNAs (lncRNAs) are emerging as promising therapeutic candidates, but their roles in imm...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Haran Sivakumaran, Sneha Nair, Mainá Bitar, Xue Lu, Lu Wang, Ji Liu, Deshapriya S. Karunarathne, P. Prakrithi, Sebastien Jacquelin, Isela Sarahi Rivera, Kristine M. Hillman, Susanne Kaufmann, Rebekah Ziegman, Wei Shi, Sarah Alexandrou, C. Elizabeth Caldon, Rakesh N. Veedu, Quan H. Nguyen, Jonathan Beesley, Michelle N. Wykes, Juliet D. French, Stacey L. Edwards
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2026-01-01
Serier:	Molecular Cancer
Fag:	Breast cancer Long noncoding RNA LncRNA BRRIAR BHLHE40 RIG-I
Online adgang:	https://doi.org/10.1186/s12943-025-02510-8
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!